Phase 2 Study of Panzem® NCD Alone and Combined With Sunitinib Malate in Patients With Metastatic Renal Cell Carcinoma
Clinical trial NCT00444314 · COMPLETED
Trial details
- NCT number
- NCT00444314
- Sponsor
- CASI pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-02-01
- Primary completion
- 2008-12-01
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.